- Report
- April 2022
- 555 Pages
Global
From €1207EUR$1,373USD£1,000GBP
- Report
- December 2021
- 446 Pages
Global
From €1207EUR$1,373USD£1,000GBP
- Report
- November 2020
- 680 Pages
Global
From €1811EUR$2,059USD£1,500GBP
- Report
- September 2020
- 251 Pages
Global
From €1201EUR$1,366USD£995GBP
- Report
- November 2023
- 140 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2024
- 135 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Report
- February 2024
- 85 Pages
Asia Pacific
From €4323EUR$4,750USD£3,706GBP
- Report
- December 2024
- 80 Pages
India
From €3185EUR$3,500USD£2,731GBP
- Report
- April 2023
- 112 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- May 2022
- 255 Pages
Global
From €3276EUR$3,600USD£2,809GBP
- Report
- April 2020
- 406 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Book
- April 2024
- 256 Pages
Wearable drug delivery devices, as a subset within the medical devices sector, encompass a range of products designed to administer medications directly to patients without the need for traditional, more invasive methods of drug administration. These devices offer continuous, controlled drug delivery, often through the skin. The market for these devices includes various technologies such as transdermal patches, insulin pumps, and other wearable injectors, catering to a range of chronic diseases, including diabetes, cardiovascular diseases, and autoimmune disorders.
Users generally appreciate these devices for their convenience, discretion, and the capability to maintain a consistent level of medication in the bloodstream, which can be particularly advantageous for the management of chronic conditions. The advances in material sciences, microelectronics, and biotechnology have been crucial in the development and improvement of these devices, offering better patient compliance and enhanced therapeutic effectiveness.
In terms of companies in the market, there are several notable entities. Insulet Corporation is known for its innovative insulin delivery systems. Medtronic offers a comprehensive range of medical devices, including wearable drug delivery solutions. Tandem Diabetes Care specializes in insulin pumps, and Dexcom develops continuous glucose monitoring systems that can integrate with wearable insulin delivery devices. Additionally, pharmaceutical giant Johnson & Johnson operates in various healthcare sectors, including the development of wearable drug delivery solutions through its subsidiary companies. Show Less Read more